Delmar Pharmaceuticals

Developer of drug candidates targeting orphan cancer indications

placeVancouver, British Columbia, Canada calendar_todayFounded 2010 groups3 employees language delmarpharma.com

Registered entities

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon